BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 2023; 29(8): 1243-1260 [PMID: 36925456 DOI: 10.3748/wjg.v29.i8.1243]
URL: https://www.wjgnet.com/1948-5182/full/v29/i8/1243.htm
Number Citing Articles
1
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicineWorld Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
2
Mariana Michelle Ramírez-Mejía, Nahum Méndez-Sánchez. From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoringWorld Journal of Gastroenterology 2024; 30(7): 631-635 doi: 10.3748/wjg.v30.i7.631
3
Abdullah Altaf, Yutaka Endo, Muhammad M. Munir, Muhammad Muntazir M. Khan, Zayed Rashid, Mujtaba Khalil, Alfredo Guglielmi, Francesca Ratti, Hugo Marques, François Cauchy, Vincent Lam, George Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Tom Hugh, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinomaHPB 2024;  doi: 10.1016/j.hpb.2024.05.006
4
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablationMeditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
5
Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablationJournal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05760-z
6
Qian Ren, Yanjun Wang. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”Annals of Surgical Oncology 2023; 30(13): 8023 doi: 10.1245/s10434-023-14444-w
7
Zhanao He, Jie Zhang, Wukui Huang. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47560-4
8
Shenyu Zhang, Guibin Yang, Ruipeng Song, Wei Wang, Fanzheng Meng, Dalong Yin, Jiabei Wang, Shugeng Zhang, Wei Cai, Yao Liu, Dayong Luo, Jizhou Wang, Lianxin Liu. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experienceTherapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241258394
9
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot. α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression RiskGastro Hep Advances 2024; 3(3): 316 doi: 10.1016/j.gastha.2023.11.018
10
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. 2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed <i>Baishideng</i> journalsWorld Journal of Gastroenterology 2024; 30(1): 9-16 doi: 10.3748/wjg.v30.i1.9
11
Xinxin Wang, Yanyan Yu, Yuqing Tao, Yueqi Wang, Chunhui Zhang, Yali Cui, Yang Zhou. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma PatientsJournal of Hepatocellular Carcinoma 2023; : 2323 doi: 10.2147/JHC.S434955
12
Yuan Tian, Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Bei Li, Geng Liu. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysisBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12162-4
13
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence predictionMedicine 2023; 102(35): e34937 doi: 10.1097/MD.0000000000034937
14
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, Inmaculada Castelló-Miralles, Moisés Diago. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinomaWorld Journal of Gastroenterology 2024; 30(19): 2512-2522 doi: 10.3748/wjg.v30.i19.2512
15
Francesco Vasuri, Stefano Chillotti, Thais Maloberti, Elisa Albertini, Giuliana Germinario, Matteo Cescon, Matteo Ravaioli, Dario de Biase, Antonia D’Errico. Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutationVirchows Archiv 2024;  doi: 10.1007/s00428-024-03791-y
16
Matheus D. Faleiro, Zuhaib M. Mir, Yara Azizieh, Stephanie E. Hiebert, Scott M. Livingstone, Mark J. Walsh, Boris L. Gala-Lopez. Oncologic Outcomes of Interventions to Decrease Allograft Ischemia-Reperfusion Injury within Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: A Systematic ReviewCurrent Oncology 2024; 31(6): 2895 doi: 10.3390/curroncol31060221
17
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen. Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patientsFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1289916
18
Dan Chen, Ayinuer Aierken, Hui Li, Ruihua Chen, Lei Ren, Kai Wang. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1232390
19
Chunhong Tian, Yifan Yu, Yuqing Wang, Lunwei Yang, Ying Tang, Chengyang Yu, Gaofei Feng, Dayong Zheng, Xiongwen Wang. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic reviewFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352873
20
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resectionCancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
21
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaBiology 2023; 12(7): 984 doi: 10.3390/biology12070984
22
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
23
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang. KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinomaCritical Reviews in Eukaryotic Gene Expression 2024;  doi: 10.1615/CritRevEukaryotGeneExpr.2024051414
24
Honghai Zhang, Shugui Sheng, Wenying Qiao, Yu Sun, Ronghua Jin. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablationFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395329
25
Lingbo Hu, Xuemei Li, Changhong Yang, Baoyong Zhou, Chengyou Du, Ning Jiang. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic reviewFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1390938
26
Ye Lu, Huanhuan Wang, Chenxia Li, Ferdos Faghihkhorasani, Cheng Guo, Xin Zheng, Tao Song, Qingguang Liu, Shaoshan Han. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinomaEuropean Journal of Surgical Oncology 2024; 50(9): 108476 doi: 10.1016/j.ejso.2024.108476
27
Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysisAbdominal Radiology 2024;  doi: 10.1007/s00261-024-04356-y
28
Jusen Nong, Kejian Yang, Tianman Li, Chenlu Lan, Xin Zhou, Junqi Liu, Haixiang Xie, Jianzhu Luo, Xiwen Liao, Guangzhi Zhu, Tao Peng. SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinomaAging 2023; 15(16): 8408 doi: 10.18632/aging.204978
29
Wei Shen, Lebin Yuan, Fei Cheng, Zhao Wu, Xiaodong Li. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltrationGenes & Genomics 2024; 46(1): 49 doi: 10.1007/s13258-023-01463-w
30
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liverHPB 2024; 26(5): 691 doi: 10.1016/j.hpb.2024.02.010
31
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102344 doi: 10.1016/j.clinre.2024.102344
32
Jian-Hong Zhong. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new eraWorld Journal of Gastroenterology 2024; 30(8): 806-810 doi: 10.3748/wjg.v30.i8.806
33
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?Cancers 2023; 15(11): 2950 doi: 10.3390/cancers15112950
34
Yutaka Endo, Muhammad Musaab Munir, Selamawit Woldesenbet, Erryk Katayama, Francesca Ratti, Hugo P Marques, François Cauchy, Vincent Lam, George A Poultsides, Minoru Kitago, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden ScoreAnnals of Surgical Oncology 2023; 30(11): 6581 doi: 10.1245/s10434-023-13825-5
35
Belinda Sánchez-Pérez, José M Ramia. Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery?World Journal of Gastrointestinal Oncology 2024; 16(2): 255-258 doi: 10.4251/wjgo.v16.i2.255